Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × Levonorgestrel × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Doxorubicin 20 Radiotherapy 19 olaparib 16 lenvatinib 16 Taxes 16 Megestrol Acetate 16 Docetaxel 15 dostarlimab 14 Specimen Handling 14 Nivolumab 14 Metformin 13 Magnetic Resonance Spectroscopy 12 durvalumab 11 Fulvestrant 11 temsirolimus 10 Medroxyprogesterone Acetate 10 Indocyanine Green 10 abemaciclib 9 Trastuzumab 9 Radiation 9 Gemcitabine 9 Brachytherapy 9 Biopsy 9 Observation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡